BOK Financial’s Veracyte VCYT Stock Holding History

BOK Financial’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$2.96K	–	1341
2025 Q1	$2.96K	Hold	100	–	–	﹤0.01%	1090
2024 Q4	$4.15K	Hold	100	–	–	﹤0.01%	1064
2024 Q3	$3.3K	Buy	+100	New	+$2.81K	﹤0.01%	1107

Other funds holding VCYT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOK Financial's VCYT Position: Q2 2025 in Review

BOK Financial sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 100 shares — an estimated $2.96K sold.

BOK Financial first reported a position in VCYT in Q3 2024 and held it in 3 quarters. The position peaked at $4.15K in Q4 2024. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.

BOK Financial reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
BOK Financial sold 100 Veracyte shares in Q2 2025, an estimated $2.96K.
BOK Financial first reported a position in Veracyte in Q3 2024 and held it in 3 quarters.
BOK Financial's Veracyte position peaked at $4.15K in Q4 2024.
278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.

Based on BOK Financial's 13F filing for Q2 2025, filed 12 Aug 2025.